8-K
Current Report
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-22-252180
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d404270d8k.htm…